Saturday, 31 October 2026European Markets

ROCHE BOBOIS And CAFOM Have A High Dividend Yield And Return On Equity In The Consumer Cyclical Sector.

Loading stream...

(vianews) - roche bobois (rbo.pa) is among this list of stock assets with the highest dividend rate and return on equity on the consumer cyclical sector.

financial asset price forward dividend yield return on equity
roche bobois (rbo.pa) €44.40 4.65% 31.48%
cafom (cafo.pa) €9.00 2.25% 6.66%

several euronext companies pay out dividends to its shareholders. the dividend yield is a dividend to price ratio showing how much a company pays out in dividends each year.

1. roche bobois (rbo.pa)

4.65% forward dividend yield and 31.48% return on equity

roche bobois s.a. engages in the furniture design and distribution business worldwide. it provides living room products, such as sofas and sofa beds, coffee tables, armchairs, wall compositions, cocktail tables, tv units, bookcases, cabinets, side tables, consoles, and occasional furniture; dining room products, including chairs, stools, benches, sideboards, dining tables, columns, dressers, and dining room storage products; desks; bedroom products comprising beds, wardrobes, bedside tables, screens, complements, and other bedroom furniture products; outdoor furniture products; and lights, cushions, rugs, mirrors, decorative objects, and home furnishings, as well as other furniture products. the company offers its products under the roche bobois and cuir center brands. as of march 31, 2022, it operated 128 owned and 210 franchised stores in 56 countries worldwide, as well as an online store. the company was formerly known as furn-invest s.a.s. roche bobois s.a. was founded in 1960 and is headquartered in paris, france.

earnings per share

as for profitability, roche bobois has a trailing twelve months eps of €2.97.

pe ratio

roche bobois has a trailing twelve months price to earnings ratio of 14.95. meaning, the purchaser of the share is investing €14.95 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 31.48%.

volatility

roche bobois's last week, last month's, and last quarter's current intraday variation average was a negative 0.07%, a positive 0.01%, and a positive 1.04%.

roche bobois's highest amplitude of average volatility was 0.48% (last week), 0.72% (last month), and 1.04% (last quarter).

volume

today's last reported volume for roche bobois is 4861 which is 228.22% above its average volume of 1481.

dividend yield

as claimed by morningstar, inc., the next dividend payment is on jul 3, 2024, the estimated forward annual dividend rate is 2.25 and the estimated forward annual dividend yield is 4.65%.

more news about roche bobois.

2. cafom (cafo.pa)

2.25% forward dividend yield and 6.66% return on equity

centrale d'achat française pour l'outre-mer société anonyme provides home furnishing products in south-east asia, south america, europe, and middle east. the company offers household appliance products and services under darty; home equipment under but; design manufacturing under habitat; natural and wellness products under the nature & discoveries; furniture, decoration, and appliances under but cosy; and musical instruments under the music & sound brands in guadeloupe, french guiana, martinique, saint-martin, reunion island, and new caledonia. it also operates vente-unique.com, a b2c platform that engages in the online sale of furniture for individuals; and directlowcost.com that supplies furniture and decoration products for distribution professionals. the company was founded in 1985 and is based in paris, france.

earnings per share

as for profitability, cafom has a trailing twelve months eps of €1.33.

pe ratio

cafom has a trailing twelve months price to earnings ratio of 6.77. meaning, the purchaser of the share is investing €6.77 for every euro of annual earnings.

return on equity

the company's return on equity, which measures the profitability of a business relative to shareholder's equity, for the twelve trailing months is 6.66%.

more news about cafom.

What we know · the intelligence behind this page
Live from the substrate
What we're seeing
ESMO 2026 Oncology Data Wave Builds Toward Ivonescimab PDUFA, While Micro-Cap Biotech Exits the Market
Late October 2026 is a dense catalyst window led by ESMO 2026. Daiichi Sankyo's DXd antibody-drug conjugate (ADC) programs (DESTINY-Lung04, DESTINY-Breast11, REJOICE-Ovarian01/02, TUXEDO-3), Guardant's 25 abstracts and the PACE-LUNG ctDNA trial all report there. These feed into the FDA's 14 November 2026 PDUFA date for ivonescimab. Large and mid-cap developers with late-stage data and commercial launches (ZEGFROVY, ANKTIVA, MIUDELLA, lorundrostat, duvakitug) are drawing capital and attention. Spago Nanomedical's board decision to seek a Nasdaq First North delisting (EGM 19 November, application 25 January 2027) shows the capital squeeze on early-stage, single-asset names (Tumorad is Phase I).
Our read on the data ›
Signals we're tracking
EPKINLY Regulatory-Clinical Success Cascade
High probability of expanded label indications, additional combination approvals, and competitive positioning strength in follicular lymphoma market. Predicts positive commercial uptake and potential accelerated review for related indications.
Patterns we're watching ›
Where sources disagree
Ford Motor Company
Both facts give cash for Ford Motor Company at the same point in time (2025-12-31; FY 2025 year-end and Q4 2025 year-end are the same date). Both are labelled USD, but the values are 23,356,000,000 and 23.356, which cannot both be true in USD. The two numbers agree once the second is read as billions (23.356 bn = 23,356,000,000), so the economic content is consistent and the conflict is a unit/scale error in the Q4 2025 record. The period is not the reason for the conflict: a Q4 and an FY figure at the same year-end date should match.
We flag conflicts openly ›
Recently verified
✓ Checked against the original source
4,994
facts traced to their source — and we flag the ones that don't hold up.
101 entities tracked4,994 facts checked against source5,514 source documents archived
Query this data → isubstrate.com